Cargando...

Triple Reuptake Inhibitors: A Premise and Promise

On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Marks, David M., Pae, Chi-Un, Patkar, Ashwin A.
Formato: Artigo
Idioma:Inglês
Publicado: Korean Neuropsychiatric Association 2008
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2796030/
https://ncbi.nlm.nih.gov/pubmed/20046357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2008.5.3.142
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!